arrow
K

Kayode Ogungbenro

The University of Manchester
H-index:32
Citation Count:4,022
Views:0

Biography

No content for now.

Education

No content for now.

Work Experience

No content for now.

Honors & Awards

No content for now.

Translational Evaluation of In Vitro-to-In Vivo Extrapolation Techniques for Brain Penetration Using Open Flow Microperfusion and Microdialysis in Rats

<strong>体外-体内外推技术在脑穿透中的应用:基于开放流微灌注和微透析在 rats 中的转化评估</strong>

2026-10-160
OA
The New Spine of Access to the Brain’s Secrets: Extracellular Vesicles from Cerebrospinal Fluid Liquid Biopsies in CNS Diseases and Blood–Brain Barrier Research

通往大脑秘密的新途径:中枢神经系统疾病和血脑屏障研究中脑脊液液体活检的细胞外囊泡

2026-07-230
OAAI
Application of modelling of cell monolayer permeation data to generate input parameters compatible with in vitro-in vivo translation of blood-brain-barrier disposition of drugs

细胞单层渗透数据的建模应用,以生成与药物血脑屏障分布的体外-体内转化相兼容的输入参数

2026-02-230
OAAI
Virtual Twin-PBPK Modelling: A Step Toward Precision Dosing in Patients with Obesity

虚拟孪生-PBPK建模:实现肥胖患者精准给药的一步

2026-01-080
OAAI
A prospective cohort feasibility study of real-time beta-lactam antimicrobial therapeutic drug monitoring in critically ill patients with lower respiratory infection: The TDM-TIME study

一项关于实时β-内酰胺抗菌药物治疗药物监测在重症下呼吸道感染患者中可行性的前瞻性队列研究:TDM-TIME研究

2025-12-010
PRE
Translatability of Animal Models for Alzheimer's Disease Using a Machine Learning Based Workflow

基于机器学习工作流程的阿尔茨海默病动物模型的可翻译性

2025-11-180
OAAI
Translation of a physiologically-based pharmacokinetic model for dabigatran etexilate to the design of a safety and efficacy study in post-partum women

达比加群酯生理药代动力学模型的翻译及其在产后妇女安全性有效性研究设计中的应用

2025-11-010
OAAI
Mathematical Modeling of Neuroinflammation in Neurodegenerative Diseases

神经退行性疾病中神经炎症的数学建模

2025-08-130
OAAI
Population Pharmacokinetic Modeling of Glycochenodeoxycholic Acid 3-O-Sulfate (GCDCA-S) as Endogenous Biomarker of OATP1B3 and OAT3 Transporters

Glycochenodeoxycholic Acid 3-O-Sulfate (GCDCA-S)作为OATP1B3和OAT3转运体的内源性生物标志物的群体药代动力学建模

2025-08-110
OAAI
Challenges and Opportunities for Incorporating Physiological Information into Pharmacokinetic Models of Intranasal Drug Delivery to the Brain: A Review of the Current Status and Future Trajectories

将生理信息整合到经鼻给药至脑的药代动力学模型中的挑战与机遇:当前状态与未来发展趋势综述

2025-06-170
PRE
Simultaneous Estimation of fm and FG Values Directly from Clinical Drug-Drug Interaction Study Data (vol 27, 83, 2025)

直接从临床药物相互作用研究数据中同时估计fm和FG值(卷27,83,2025)

2025-05-160
OA
Simultaneous Estimation of fm and FG Values Directly from Clinical Drug-Drug Interaction Study Data

直接从临床药物相互作用研究数据中同时估计fm和FG值

2025-04-290
OA
Transporter expressions as part of required scaling factor to support in vitro in vivo extrapolation for blood-brain barrier drug permeability
2025-01-010
OA
Recommended approaches for integration of population pharmacokinetic modelling with precision dosing in clinical practice
2024-11-211
OA
Hierarchical cluster analysis and nonlinear mixed-effects modelling for candidate biomarker detection in preclinical models of cancer.
2024-06-011
OA
Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
2024-05-230
OAAI
Covariates in population pharmacokinetic studies of critically ill adults receiving β-lactam antimicrobials: a systematic review and narrative synthesis

接受 β-内酰胺抗菌药物的重症成年人群体药代动力学研究中的协变量: 系统综述和叙述性综合

2024-02-261
OAAI
Radiation in Combination with Immune Checkpoint Blockade and DNA Damage Response Inhibitors in Mice: Dosage Optimization in MC38 Syngeneic Tumors via Modelling and Simulation
2023-10-014
OAAI
Mixed effects modeling of radiotherapy in combination with immune checkpoint blockade or inhibitors of the DNA damage response pathway
2023-09-183
OA
Use of In Vivo Imaging and Physiologically-Based Kinetic Modelling to Predict Hepatic Transporter Mediated Drug-Drug Interactions in Rats
2023-03-104
OAAI